ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly other investing activities, net ($M) ($M)
Quarterly figures from Eli Lilly's filings and investor materials
Latest, Q2 2026
-127
Period ended Jun 30, 2026
Change on a year earlier
-190.1%
141 in Q2 2025
History
68 quarters
Since Q3 2008
Sources
48
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other investing activities, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -127 | -190.1% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -31 | -127.9% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 56.8 | -108.4% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | -308 | -182.5% | Form 10-Q (filed 2026-08-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 141 | +34.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 111 | -330.3% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | -678 | -1,053.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 373 | -156.0% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 105 | -77.0% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -48.2 | -219.6% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 71.1 | +122.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2023 | Sep 30, 2023 | -666 | +199.0% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 457 | +1,967.0% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 40.3 | -130.2% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | 31.9 | -116.9% | Form 10-K (filed 2024-02-21) ↗ |
| Q3 2022 | Sep 30, 2022 | -223 | +318.8% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 22.1 | -69.5% | Form 10-Q (filed 2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | -133 | +509.1% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Dec 31, 2021 | -189 | -318.5% | Form 10-K (filed 2024-02-21) ↗ |
| Q3 2021 | Sep 30, 2021 | -53.2 | -536.1% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | 72.4 | -253.1% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | -21.9 | -142.6% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 86.5 | -62.7% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | 12.2 | -108.6% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | -47.3 | -201.9% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 51.4 | -113.3% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 232 | +20,990.9% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | -142 | -1.4% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 46.4 | -292.5% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | -386 | +1,718.9% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 1.10 | -62.1% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | -144 | +134.9% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | -24.1 | -77.9% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | -21.2 | +171.8% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 2.90 | -105.3% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2017 | Sep 30, 2017 | -61.1 | +41.1% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | -109 | -2,421.3% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | -7.80 | -78.6% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | -55 | +78.0% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2016 | Sep 30, 2016 | -43.3 | +5.6% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 4.70 | -108.0% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | -36.5 | +1,251.9% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | -30.9 | -109.2% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | -41 | -84.0% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -59 | -10.5% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | -2.70 | -92.7% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 334 | – | Form 10-Q (filed 2015-10-30) ↗ |
| Q3 2014 | Sep 30, 2014 | -256 | – | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2014 | Jun 30, 2014 | -65.9 | +76.7% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2014 | Mar 31, 2014 | -36.9 | +100.5% | Form 10-Q (filed 2015-04-30) ↗ |
| Q2 2013 | Jun 30, 2013 | -37.3 | +41.8% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | -18.4 | +6.4% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 126 | – | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2012 | Sep 30, 2012 | -18.2 | -1,920.0% | Form 10-Q (filed 2013-07-26) ↗ |
| Q2 2012 | Jun 30, 2012 | -26.3 | – | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2012 | Mar 31, 2012 | -17.3 | -49.6% | Form 10-Q (filed 2013-04-26) ↗ |
| Q2 2011 | Sep 30, 2011 | 1 | -104.4% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | -34.3 | +226.7% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | -140 | +488.6% | Form 10-K (filed 2011-02-22) ↗ |
| Q3 2010 | Sep 30, 2010 | -22.5 | -29.0% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | -46.8 | +132.8% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | -10.5 | -44.7% | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | -23.7 | -93.6% | Form 10-Q (filed 2010-10-29) ↗ |
| Q3 2009 | Sep 30, 2009 | -31.7 | -266.0% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | -20.1 | – | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2009 | Mar 31, 2009 | -19 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2008 | Dec 31, 2008 | -370 | – | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2008 | Sep 30, 2008 | 19.1 | – | Form 10-Q (filed 2009-10-30) ↗ |
Cite this data
StockData. (2026). Eli Lilly Other investing activities, net ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_oth_inv
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.